Herantis Pharma has been conducting a study of their treatment for Parkinson’s disease, which is cerebral dopamine neurotrophic factor (CDNF). Phase 1/2 has been
According to an article in BioSpace, the FDA recently approved the PARP inhibitor Lynparza that was developed by Merck and AstraZeneca to be used
According to a story from Medgadget, a team of scientists from Columbia University have been working on a robotic device that could assist patients with
January is Cervical Health Awareness Month! The New Year holiday is all about taking stock of one’s self and making efforts to improve or set
Doctor Daniel Kastner, director of NHGRI, recently uncovered a new rare disease along with his research team. It’s called CRIA syndrome. This discovery has been
A New Working Group A team of healthcare professionals from the Institute for Quality and Efficacy in Health Care, the Drug Commission of the German
© Copyright Patient Worthy
